已收盤 10-03 16:00:00 美东时间
+0.020
+0.33%
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced one late-breaker oral platform presentation and two poster presentations to be presented at the International Congress of Parkinson's Disease and Movement
10-02 21:06
SALT LAKE CITY, Aug. 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with eff...
08-26 20:00
Gabelli Equity Trust (NYSE:GAB) declares $0.15/share quarterly dividend, in line with previous. Forward yield 10.08% Payable Sept. 23; for shareholders of record Sept. 16; ex-div Sept. 16. See GAB Div...
08-22 00:13
Gabelli Convertible and Income Securities Fund的董事会宣布每股0.12美元的现金分配,将于9月23日支付,记录日期为9月16日。该基金计划支付其净资产价值8%的最低年度分配。董事会将根据净值和市场环境监控分配水平。部分分配可能被视为长期资本收益或合格股息,需缴纳20%联邦税率,符合条件者还需缴纳3.8% Medicare附加税。最终确定分配构成将在年底完成,投资者将通过Form 1099-DIV收到详细信息。
08-21 17:55
<p>The Board of Trustees of The Gabelli Dividend & Income Trust (NYSE:GDV) has approved a 27% increase in its annual distribution to $1.68 per share, with $0.14 monthly payments starting in January 2025. Distributions for October, November, and December 2025 are set at $0.14 per share, with record and payable dates specified. The Board will continue evaluating strategic opportunities and monitoring market conditions. All or part of the distributi...
08-21 17:09
The Gabelli Equity Trust Inc. has reaffirmed and satisfied its 10% distribution policy by declaring a $0.15 per share cash distribution. The distribution will be paid on September 23, 2025, to shareholders of record on September 16, 2025. The Fund aims to pay a minimum annual distribution based on its average net asset value or meet IRS requirements. Each quarter, the Board reviews potential distributions from income, realized capital gains, or a...
08-21 15:46
An announcement from Gabriel India Limited ( ($IN:GABRIEL) ) is now available. ...
08-18 01:22
VGCC antibody testing in conjunction with neurologic consultation can diagnose LEMSAmifampridine may be considered as a supportive care treatmentGuideline inclusion may raise clinical awareness of cancer-associated LEMS
08-06 20:18
绿叶制药集团宣布,其自主研发的1类创新药LY03021在中国开展的I期临床研究已完成首例受试者入组。LY03021为去甲肾上腺素转运体(NET)/多巴胺转运体...
08-03 18:06
Gabriel India Limited ( ($IN:GABRIEL) ) just unveiled an update. Gabriel India ...
07-30 03:32